BioNTech
BNTX
280 hedge funds and large institutions have $4.72B invested in BioNTech in 2025 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 75 increasing their positions, 100 reducing their positions, and 58 closing their positions.
0.23% more ownership
Funds ownership: 21.35% → 21.58% (+0.23%)
8% less funds holding
Funds holding: 303 → 280 (-23)
13% less call options, than puts
Call options by funds: $137M | Put options by funds: $157M
19% less capital invested
Capital invested by funds: $5.79B → $4.72B (-$1.07B)
25% less repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 100
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
31% less first-time investments, than exits
New positions opened: 40 | Existing positions closed: 58
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of New York Mellon
New York
|
+$77.8M |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
+$65.1M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$62.5M |
| 4 |
Millennium Management
New York
|
+$41.8M |
| 5 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$41.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$46.8M |
| 2 |
FAM
Fred Alger Management
New York
|
-$45.2M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$35.8M |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
-$35.3M |
| 5 |
Primecap Management
Pasadena,
California
|
-$27.9M |
BNTX Hedge Fund Activity: Q1 2025 in Review
280 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in BioNTech (BNTX) for Q1 2025, worth a combined $4.72B — down 19% from $5.79B a quarter earlier.
Sellers outnumbered buyers: 58 funds closed out of BNTX and 40 opened new positions — a net loss of 18 holders — while 100 trimmed existing stakes and 75 added.
The largest buyer was Bank of New York Mellon, adding an estimated $77.8M. The largest seller was Fidelity Investments, cutting an estimated $46.8M.
- 280 institutional investors held BioNTech (BNTX) as of Q1 2025, down from 303 in Q4 2024.
- Funds reported $4.72B of BioNTech stock for Q1 2025, down 19% quarter-over-quarter.
- 40 funds opened new BioNTech positions in Q1 2025 and 58 closed out, a net change of -18 holders.
- The largest BioNTech buyer in Q1 2025 was Bank of New York Mellon, an estimated $77.8M added.
- The largest BioNTech seller in Q1 2025 was Fidelity Investments, an estimated $46.8M sold.
Based on aggregated 13F filings for Q1 2025.